In the latest episode of the “Patient Perspectives” Podcast, Karl Freemyer, Head of BD at FIECON, a Herspiegel company, speaks with Simon Anthony Richey, a patient living with idiopathic pulmonary fibrosis (IPF).

Simon’s journey into diagnosis was unusual – what started as a seemingly minor symptom led to a scan that revealed fibrosis in his lungs. Unlike many patients who endure years of misdiagnosis, Simon’s path to clarity was comparatively swift. Yet, the real challenge came after: navigating treatment access.

Listen to the episode to find out: How many consults did Simon take before receiving clarity? How did access barriers and drug costs impact his treatment decisions? What innovations are most urgently needed in IPF over the next five years?